Get the Stockscreener App
0.70
2.94%
+0.02
Regen Biopharma, Inc. Stock (RGBP) Forecast
The Regen Biopharma, Inc. (RGBP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00383, representing a -99.45% decrease from the current price of $0.70. The highest analyst price target is $0.00733, and the lowest is $0.000338.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RGBP Price Target
Average 0.00367
(-99.48% Downside)
Long-term RGBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Regen Biopharma, Inc. financial reports and earnings history, Regen Biopharma, Inc. (RGBP) stock could reach $0.0145 by 2030, $0.0448 by 2040 and $0.0649 by 2050. See the projected annual prices until 2050 of the Regen Biopharma, Inc. stock below:
- Regen Biopharma, Inc. (RGBP) is expected to reach an average price of $0.0298 in 2035, with a high prediction of $0.0299 and a low estimate of $0.0304. This indicates an $-95.74% rise from the last recorded price of $0.70.
- Regen Biopharma, Inc. (RGBP) stock is projected to chart a bullish course in 2040, with an average price target of $0.0461, representing an $-93.41% surge from its current level. The forecast ranges from a conservative $0.0457 to a sky-high $0.0448.
- Our analysts predict Regen Biopharma, Inc. (RGBP) to jump -91.22% by 2045, soaring from $0.0509 to an average price of $0.0615, potentially reaching $0.0662. While $0.0509 is the low estimate, the potential upside is significant.
- Regen Biopharma, Inc. (RGBP) stock is expected to climb by 2050, reaching an average of $0.0641, a $-90.84% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.0649 and $0.0634, respectively, highlighting the market's uncertainty.
Regen Biopharma, Inc. Stock (RGBP) Year by Year Forecast
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2024
Our forecast for RGBP stock price in 2024 now indicates an average price target of $0.00367 with a high forecast of $0.00733 and a low forecast of $0.000012. The average prediction reflects an decrease of -99.48% from the last recorded price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $0.00449 | $0.000338 | $0.00733 | -99.36% |
| June, 2024 | $0.00124 | $0.000575 | $0.00455 | -99.82% |
| July, 2024 | $0.00075 | $0.00015 | $0.0034 | -99.89% |
| August, 2024 | $0.0009 | $0.000012 | $0.0012 | -99.87% |
| September, 2024 | $0.000288 | $0.000013 | $0.00129 | -99.96% |
| October, 2024 | $0.00353 | $0.000425 | $0.00418 | -99.50% |
| November, 2024 | $0.000791 | $0.000244 | $0.00586 | -99.89% |
| December, 2024 | $0.000219 | $0.000297 | $0.00203 | -99.97% |
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2025
Regen Biopharma, Inc. Stock (RGBP) is expected to reach an average price of $0.00231 in 2025, with a high prediction of $0.00439 and a low estimate of $0.000225. This indicates an -99.67% fall from the last recorded price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.000706 | $0.00114 | $0.000659 | -99.90% |
| February, 2025 | $0.000894 | $0.000578 | $0.000694 | -99.87% |
| March, 2025 | $0.00105 | $0.00122 | $0.000881 | -99.85% |
| April, 2025 | $0.00158 | $0.000831 | $0.00439 | -99.77% |
| May, 2025 | $0.00154 | $0.000225 | $0.00168 | -99.78% |
| June, 2025 | $0.00188 | $0.00166 | $0.00128 | -99.73% |
| July, 2025 | $0.0016 | $0.00184 | $0.00169 | -99.77% |
| August, 2025 | $0.00218 | $0.00241 | $0.00191 | -99.69% |
| September, 2025 | $0.000559 | $0.00274 | $0.0032 | -99.92% |
| October, 2025 | $0.00205 | $0.000622 | $0.00292 | -99.71% |
| November, 2025 | $0.00262 | $0.00302 | $0.00183 | -99.63% |
| December, 2025 | $0.00327 | $0.00377 | $0.00297 | -99.53% |
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2026
The predicted value for Regen Biopharma, Inc. (RGBP) in 2026 is set at an average of $0.00414. Estimates vary from a peak of $0.0062 to a trough of $0.00208, indicating an -99.41% surge from the present price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.00333 | $0.00311 | $0.00313 | -99.52% |
| February, 2026 | $0.00359 | $0.00362 | $0.0032 | -99.49% |
| March, 2026 | $0.00133 | $0.00208 | $0.0047 | -99.81% |
| April, 2026 | $0.00433 | $0.0031 | $0.00323 | -99.38% |
| May, 2026 | $0.00428 | $0.00438 | $0.00375 | -99.39% |
| June, 2026 | $0.0041 | $0.00438 | $0.00425 | -99.41% |
| July, 2026 | $0.00455 | $0.00483 | $0.00435 | -99.35% |
| August, 2026 | $0.00241 | $0.00505 | $0.0062 | -99.66% |
| September, 2026 | $0.0049 | $0.00353 | $0.0036 | -99.30% |
| October, 2026 | $0.00533 | $0.00573 | $0.00462 | -99.24% |
| November, 2026 | $0.00583 | $0.00633 | $0.00553 | -99.17% |
| December, 2026 | $0.00577 | $0.00564 | $0.00557 | -99.18% |
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Regen Biopharma, Inc. (RGBP) is $0.00709, with a high forecast of $0.0092 and a low forecast of $0.00498. This indicates an -98.99% decrease from the last price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.00591 | $0.00603 | $0.00555 | -99.16% |
| February, 2027 | $0.00419 | $0.00637 | $0.0077 | -99.40% |
| March, 2027 | $0.00711 | $0.00498 | $0.00601 | -98.98% |
| April, 2027 | $0.00693 | $0.00709 | $0.00644 | -99.01% |
| May, 2027 | $0.0066 | $0.00691 | $0.00681 | -99.06% |
| June, 2027 | $0.00693 | $0.00723 | $0.00679 | -99.01% |
| July, 2027 | $0.0105 | $0.00736 | $0.0092 | -98.50% |
| August, 2027 | $0.00774 | $0.00643 | $0.00644 | -98.89% |
| September, 2027 | $0.00805 | $0.00845 | $0.0074 | -98.85% |
| October, 2027 | $0.00857 | $0.00907 | $0.00807 | -98.78% |
| November, 2027 | $0.00821 | $0.00817 | $0.00809 | -98.83% |
| December, 2027 | $0.00822 | $0.00843 | $0.00789 | -98.83% |
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2028
In 2028, Regen Biopharma, Inc. (RGBP) is projected to reach an average price of $0.0108, with a high projection of $0.0137 and a low estimate of $0.00789. This indicates an -98.46% fall from the last price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.00714 | $0.00789 | $0.0107 | -98.98% |
| February, 2028 | $0.00989 | $0.00885 | $0.00879 | -98.59% |
| March, 2028 | $0.00959 | $0.00981 | $0.00913 | -98.63% |
| April, 2028 | $0.00929 | $0.00944 | $0.00938 | -98.67% |
| May, 2028 | $0.0093 | $0.00955 | $0.00923 | -98.67% |
| June, 2028 | $0.0135 | $0.00968 | $0.0122 | -98.07% |
| July, 2028 | $0.0106 | $0.00934 | $0.00928 | -98.49% |
| August, 2028 | $0.0108 | $0.0112 | $0.0102 | -98.46% |
| September, 2028 | $0.0112 | $0.0117 | $0.0107 | -98.41% |
| October, 2028 | $0.0106 | $0.0107 | $0.0107 | -98.48% |
| November, 2028 | $0.0105 | $0.0108 | $0.0102 | -98.50% |
| December, 2028 | $0.0101 | $0.0109 | $0.0137 | -98.56% |
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2029
The 2029 price forecast for Regen Biopharma, Inc. Stock (RGBP) is $0.0137 on average, with a high prediction of $0.0167 and a low estimate of $0.0108. This represents an -98.04% decrease from the previous price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0127 | $0.0108 | $0.0116 | -98.19% |
| February, 2029 | $0.0122 | $0.0125 | $0.0118 | -98.25% |
| March, 2029 | $0.0118 | $0.012 | $0.012 | -98.31% |
| April, 2029 | $0.0117 | $0.012 | $0.0117 | -98.33% |
| May, 2029 | $0.0165 | $0.012 | $0.0152 | -97.64% |
| June, 2029 | $0.0124 | $0.0122 | $0.0113 | -98.23% |
| July, 2029 | $0.0135 | $0.0135 | $0.013 | -98.07% |
| August, 2029 | $0.0138 | $0.0143 | $0.0133 | -98.04% |
| September, 2029 | $0.0132 | $0.0132 | $0.0132 | -98.11% |
| October, 2029 | $0.0128 | $0.0131 | $0.0129 | -98.17% |
| November, 2029 | $0.013 | $0.0132 | $0.0167 | -98.14% |
| December, 2029 | $0.0155 | $0.0137 | $0.0144 | -97.79% |
Regen Biopharma, Inc. Stock (RGBP) Price Forecast for 2030
Regen Biopharma, Inc. Stock (RGBP) is expected to reach an average price of $0.017 in 2030, with a high forecast of $0.0197 and a low forecast of $0.0143. This signifies an -97.57% decrease from the last price of $0.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0149 | $0.0153 | $0.0145 | -97.87% |
| February, 2030 | $0.0144 | $0.0145 | $0.0146 | -97.95% |
| March, 2030 | $0.0143 | $0.0145 | $0.0141 | -97.96% |
| April, 2030 | $0.0195 | $0.0143 | $0.0182 | -97.21% |
| May, 2030 | $0.0152 | $0.0152 | $0.0141 | -97.82% |
| June, 2030 | $0.0161 | $0.0164 | $0.0158 | -97.70% |
| July, 2030 | $0.0163 | $0.0166 | $0.0158 | -97.66% |
| August, 2030 | $0.0157 | $0.0158 | $0.0158 | -97.76% |
| September, 2030 | $0.0152 | $0.0155 | $0.0153 | -97.83% |
| October, 2030 | $0.0159 | $0.0155 | $0.0197 | -97.72% |
| November, 2030 | $0.0175 | $0.0166 | $0.0172 | -97.50% |
| December, 2030 | $0.0176 | $0.018 | $0.0172 | -97.49% |
0.77%
0.74%
Cap:
|
Volume (24h):